SUMIMARY Eleven patients with acute congestive heart failure were studied during treatment with a loop diuretic. Plasma concentrations of atrial natriuretic peptide were considerably increased before treatment and with successful treatment returned progressively towards normal values. There was a statistically significant correlation between plasma atrial natriuretic peptide concentration and both jugular venous pressure and change of body weight.
SUMIMARY Eleven patients with acute congestive heart failure were studied during treatment with a loop diuretic. Plasma concentrations of atrial natriuretic peptide were considerably increased before treatment and with successful treatment returned progressively towards normal values. There was a statistically significant correlation between plasma atrial natriuretic peptide concentration and both jugular venous pressure and change of body weight.
These results support the hypothesis that atrial distension is an important stimulus to atrial natriuretic peptide release. Furthermore, the close relation between plasma concentrations of atrial natriuretic peptide and clinical improvement in these patients suggests that measurement of plasma atrial natriuretic peptide concentration could provide a clinically useful and non-invasive method of monitoring the response to treatment.
Soon after the discovery that high concentrations of peptides with potent natriuretic properties are stored in atrial muscle cells,' it was proposed that atrial distension caused by changes of extracellular fluid volume might act as a stimulus to the release of atrial natriuretic peptide into the circulation, and that atrial natriuretic peptide could thus act as a natriuretic hormone.2 The intravenous infusion of sufficient quantities of saline or colloid to raise atrial pressure has been shown to produce a dose dependent plasma release of atrial natriuretic peptide in laboratory animals34 and human beings. the group as a whole (r = 0-62, p < 0-001). Similarly within the group plasma atrial natriuretic peptide concentration correlated significantly with body weight (r = 0 59, p < 0-01). A similar pattern of response to treatment was seen irrespective of the aetiology of the congestive heart failure.
Discussion
Soon after the isolation, sequencing, and synthesis of the atrial peptides, Sagnella and MacGregor postulated that atrial natriuretic peptide was a natriuretic hormone and that atrial distension was a major stimulus to atrial natriuretic peptide release.2 Evidence supporting this hypothesis includes that of Lang and his colleagues who showed that raising the filling pressure of an isolated heart preparation increased atrial natriuretic peptide release from the heart. We studied patients presenting consecutively for emergency treatment in hospital and we used specific but broad selection criteria so that our findings would be relevant to routine clinical practice. In this group ofpatients there was naturally some variation in drug treatment and in the aetiology of the heart failure. The fact that this variability did not prevent a clear relation between the observed indices of the clinical severity of the heart failure and the circulating concentrations of atrial natriuretic peptide from emerging reinforces the general applicability of our observation.
We have shown that plasma concentrations of atrial natriuretic peptide are raised for some days as a result of acute congestive heart failure. The pathophysiological importance of this finding remains to be explained. Clearly the high concentrations of atrial natriuretic peptide were not causing a diuresis and natriuresis of sufficient magnitude to alleviate the condition spontaneously. This may be due in part to the activation of the sodium-conserving reninangiotensin-aldosterone system that is known to occur in heart failure. '5 16 Acute congestive heart failure produces sustained increases of atrial pressure. Monitoring of atrial pressure can provide an important guide to clinical management."' Thus we speculate that if circulating concentrations ofatrial natriuretic peptide are indeed related to atrial distension, as the present study would suggest, monitoring of the plasma atrial natriuretic peptide concentration could provide a clinically useful non-invasive index ofthe response to treatment. Despite the intense medical and scientific interest generated by the discovery of atrial natriuretic peptide,'8'9 little information of direct relevance to the general physician has so far emerged. We therefore feel that this speculative hypothesis warrants further clinical investigation.
Currently clinical application of plasma atrial natriuretic peptide assays would be limited by the need for plasma extraction and relatively long assay incubation times. The assay used in this study had a two day extraction step followed by a four day incubation. Overnight assay incubation gives accep- 
